265 related articles for article (PubMed ID: 24906763)
1. Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: preparation, characterization, and evaluation.
Yao Y; Xie Y; Hong C; Li G; Shen H; Ji G
Carbohydr Polym; 2014 Sep; 110():329-37. PubMed ID: 24906763
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
3. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
4. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
5. Characterization and antioxidant activity of the complexes of tertiary butylhydroquinone with β-cyclodextrin and its derivatives.
Pu H; Sun Q; Tang P; Zhao L; Li Q; Liu Y; Li H
Food Chem; 2018 Sep; 260():183-192. PubMed ID: 29699660
[TBL] [Abstract][Full Text] [Related]
6. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of Microemulsions of Myricetin for Improving Its Antiproliferative and Antioxidative Activities and Oral Bioavailability.
Guo RX; Fu X; Chen J; Zhou L; Chen G
J Agric Food Chem; 2016 Aug; 64(32):6286-94. PubMed ID: 27455843
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
Liu M; Cao W; Sun Y; He Z
Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
[TBL] [Abstract][Full Text] [Related]
9. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-
Han D; Han Z; Liu L; Wang Y; Xin S; Zhang H; Yu Z
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991574
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
[TBL] [Abstract][Full Text] [Related]
11. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of the inclusion complex of Baicalin (BG) with beta-CD and HP-beta-CD in solution: an antioxidant ability study.
Li J; Zhang M; Chao J; Shuang S
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Aug; 73(4):752-6. PubMed ID: 19423384
[TBL] [Abstract][Full Text] [Related]
13. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
Hong C; Dang Y; Lin G; Yao Y; Li G; Ji G; Shen H; Xie Y
Int J Pharm; 2014 Dec; 477(1-2):251-60. PubMed ID: 25445518
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of 16-dehydropregnenolone hydroxypropyl-β-cyclodextrin inclusion complex following peroral administration.
Sun Y; Jia L; Zhou H; Mao M; Wang X; Wei L; Sun L
Pharm Dev Technol; 2017 Mar; 22(2):218-228. PubMed ID: 27269370
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
17. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
Celebioglu A; Yildiz ZI; Uyar T
Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
[TBL] [Abstract][Full Text] [Related]
18. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water solubility and slow release of curcumin.
Aytac Z; Uyar T
Int J Pharm; 2017 Feb; 518(1-2):177-184. PubMed ID: 28057465
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
20. Inclusion complex of barbigerone with hydroxypropyl-β-cyclodextrin: preparation and in vitro evaluation.
Qiu N; Cheng X; Wang G; Wang W; Wen J; Zhang Y; Song H; Ma L; Wei Y; Peng A; Chen L
Carbohydr Polym; 2014 Jan; 101():623-30. PubMed ID: 24299819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
